Europe’s blind spot on rare kidney diseases
Analysis Summary
- Propaganda Score
- 0% (confidence: 95%)
- Summary
- The article discusses delays in diagnosing rare kidney diseases, featuring expert analysis on the consequences of late diagnosis and proposed solutions like integrated screening programs. It highlights structural challenges in healthcare systems and calls for policy changes to improve early detection and treatment access.
Fact-Check Results
“A Euronews Health Summit debate in Brussels brought together policymakers, clinicians and patient representatives to examine why delays in diagnosis remain so common.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm or refute the existence of the Euronews Health Summit debate.
“The panel, titled Racing Against Time: Europe’s Rare Kidney Disease Challenge, featured new data from Sobi’s Rare Kidney Disease Barometer.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify the panel's title or Sobi's data inclusion.
“One third of patients waited more than three years and in some cases patients waited up to five years to be diagnosed.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to support or challenge the reported wait time statistics.
“Urine testing is grossly underused... only 50 per cent of people with diabetes have a urine test, despite once-a-year guidelines.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm urine testing rates or guideline adherence.
“Newer targeted therapies can also delay disease progression, if patients are identified in time.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify the efficacy of targeted therapies or diagnosis timing.
“The case for CRM screening includes reference to Japan as proof of concept, where structured health checks have been shown to be both feasible and effective.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to confirm Japan's role as a proof of concept for CRM screening.
“Differences in healthcare systems, funding priorities and awareness continue to shape outcomes for patients.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to support or refute healthcare system differences impacting outcomes.
“The tools and data exist. The question is whether healthcare systems can move quickly enough to diagnose and treat patients before it is too late.”
❓
INSUFFICIENT EVIDENCE
— No evidence in archive to verify the availability of tools/data for timely diagnosis.